Epstein Secrets

litate your discussions with the applicable Goldman Sachs entity including, but not limited to, Goldman Sachs & Co. LLC, Goldman Sachs International, Goldman Sachs AG, Goldman Sachs Bank (Europe) plc, Goldman Sachs Paris Inc. et Cie., Goldman Sachs (Monaco) S.A.M., Goldman Sachs Saudi Arabia, Goldman Sachs Bank AG,

, Goldman Sachs (Monaco) S.A.M., Goldman Sachs Saudi Arabia, Goldman Sachs Bank AG, GS International, Sucursal en Espana, Goldman Sachs (Asia) L.L.C, Goldman Sachs (Singapore) Pte (Company Number: 19862165W), Goldman Sachs Australia Pty Limited, and Brazil by Goldman Sachs do Brasil Banco Multiplo S.A. as to the opportunities a

r or Solicitation. This material may not, without Goldman Sachs' prior written consent, be (i) copied, photocopied

, Sucursal en Espana, Goldman Sachs (Asia) L.L.C, Goldman Sachs (Singapore) Pte (Company Number: 19862165W), Goldman Sachs Austra

) L.L.C., Seoul Branch; in Japan by Goldman Sachs (Japan) Ltd; in Australia by Goldman Sachs Australia Pty Ltd (ACN 006 797 897); and in Singapore by Goldman Sachs (Singapore) Pte. (Company Number: 19862165W). In Australia, this document, and any access to it, is intended only for a person that has first satisfied Goldman Sach

to Assign: OTC derivative transactions entered into with one or more affiliates of Goldman Sachs cannot be assigned or otherwise transferred without Goldman Sachs’ prior written consent and, therefore, it may be impossible for you to transfer any OTC derivative transaction to a third party. — Counterparty Credi